PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Austin Pathology, Austin Health, Heidelberg, Vic, Australia; Department of Infectious Diseases, Austin Health, Heidelberg, Vic, Australia. Electronic address: kyra.chua@austin.org.au.\', \'Department of Medicine (St Vincent\'s Hospital), The University of Melbourne, Fitzroy, Vic, Australia.\', \'Austin Pathology, Austin Health, Heidelberg, Vic, Australia.\', \'Department of Respiratory Medicine, Austin Health, Heidelberg, Vic, Australia.\', \'Department of Infectious Diseases, Austin Health, Heidelberg, Vic, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0031-3025(20)30926-010.1016/j.pathol.2020.09.003
?:doi
?:hasPublicationType
?:journal
  • Pathology
is ?:pmid of
?:pmid
?:pmid
  • 33039094
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.944
?:rankingScore_hIndex
  • 56
?:title
  • Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all